{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-23-001762","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.205072+00:00","generated_at":"2026-06-10T06:54:20.669642+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Renovaro to acquire AI health company GEDi Cube in stock-for-stock deal; combined company to focus on precision medicine","bullets":["GEDi Cube holders to receive ~50% of Renovaro common stock (subject to adjustments); supermajority (78%) of GEDi holders support deal.","Transaction expected to close late Q4 2023 or early 2024, subject to Renovaro shareholder approval and other conditions.","Combined company plans to launch AI-based commercial diagnostic products in 2024; Renovaro aims to start Phase 1/2 pancreatic cancer trial in H2 2024.","GEDi Cube validated early lung cancer diagnosis at a university hospital; technology targets 12 additional cancers including pancreatic and breast.","Renovaro's pre-clinical and clinical data expected to accelerate GEDi's AI, which in turn could advance Renovaro's therapy development."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-23-001762","json":"https://secwatch.observer/filing/0001731122-23-001762.json","markdown":"https://secwatch.observer/filing/0001731122-23-001762.md","text":"https://secwatch.observer/filing/0001731122-23-001762.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001762/0001731122-23-001762-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001762/e5071_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:54:20.669642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aa9671980569fa3d49cf56dc68623a3b39a3d48a","claim":"Lunai Bioworks Inc. entered into Purchase Agreement with GEDi Cube Intl Ltd. (effective 2023-09-28).","evidence_excerpt":"On September 28, 2023, Renovaro Biosciences Inc. (NASDAQ: RENB) (“ Renovaro ”), entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) with GEDi Cube Intl Ltd.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112223001762/0001731122-23-001762-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"GEDi Cube Intl Ltd."},{"label":"Effective","value":"2023-09-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}